Synthetic DNA/RNA Controls and Reference Standards Supply

The contract involves the supply of synthetic RNA spike-in controls and tumor mutational burden (TMB) reference standards, which serve as calibration materials essential for genomic testing and next-generation sequencing (NGS) workflows. These materials are critical for ensuring accuracy and reliability in genomic analyses, particularly in clinical and research settings involving tumor profiling. The procurement falls under the subcontract category with a focus on providing high-quality synthetic DNA and RNA controls to support advanced molecular diagnostics. Issued by the Naval Medical Research Center under the Department of Defense, the contract's place of performance is designated at Tripler Army Medical Center. The solicitation was posted on May 27, 2026, with a response deadline of June 1, 2026. The relevant industry classification is within the chemical manufacturing sector, specifically under NAICS code 325414, which includes biological product manufacturing. This contract underscores the importance of precise calibration materials in enhancing the performance and accuracy of genomic testing methodologies in defense-related medical research.